1. Home
  2. Additional Resources
  3. Peer-reviewed Articles and Reports
  4. Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States

Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States

This is an academic paper that explores how methadone and buprenorphine capacity vary by race/ethnicity. Study findings show that counties with highly segregated black/African American and Hispanic/Latinx communities had more facilities to provide methadone per capita, while counties with highly segregated white communities had more facilities to provide buprenorphine per capita, highlighting the need for racial equity and justice. 

Resource Type
Peer-reviewed Articles and Reports
Continuum of Care
Treatment
Response Approach
Medications for Opioid Use Disorder
Peer-reviewed Article
Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States
Citation

Goedel, W.C., Shapiro, A., Cerdá, M., Tsai, J.W., Hadland, S.E., Marshall, B.D.L. (2020). Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States. JAMA Network Open, 3(4), e203711.